Welcome to our dedicated page for Zions Bancorporation N A SEC filings (Ticker: ZION), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Zions Bancorporation, N.A. (NASDAQ: ZION) SEC filings page on Stock Titan provides access to the bank’s regulatory disclosures, including current reports on Form 8-K and other key documents filed with the U.S. Securities and Exchange Commission. Zions Bancorporation, N.A. is a national banking association organized in the United States, with Commission File Number 001-12307, and it files under the Securities Exchange Act of 1934.
Recent Form 8-K filings from Zions Bancorporation, N.A. include reports of quarterly financial results under Item 2.02, where the bank furnishes earnings press releases and supplemental presentations as exhibits. These filings describe net earnings, balance sheet metrics, and commentary from management, and they are explicitly identified as being furnished rather than filed for certain liability purposes. Other 8-K filings contain detailed forward-looking statement disclosures, outlining risks related to loan and securities portfolios, deposit composition, economic and political conditions, interest rate changes, regulatory developments, technology and cybersecurity, and reputational factors.
Through Stock Titan, users can review these filings alongside AI-powered summaries that explain the main points of lengthy documents such as earnings releases and risk disclosures. Real-time updates from the SEC’s EDGAR system ensure that new 8-Ks and other forms appear promptly, while AI-generated overviews help readers interpret complex language and identify key themes.
Investors can also use this page to track information relevant to Zions Bancorporation, N.A.’s capital structure, including references to its NASDAQ-listed common stock (ZION) and NYSE-listed Series A preferred shares (ZIONP). As additional forms such as annual reports on Form 10-K, quarterly reports on Form 10-Q, and insider transaction reports on Form 4 are filed, they can be accessed here with AI assistance to highlight significant developments, governance items, and risk factors.
Zions Bancorporation, N.A. reported that it sold 460,153 Class B-1 shares of Visa Inc. on May 4, 2026. The sale generated aggregate proceeds of $215 million, producing a pre-tax gain of approximately the same amount. This gain will be recognized in the bank’s results for the second quarter of 2026, adding a sizable one-time boost to earnings for that period.
Zions Bancorporation, National Association reported the results of its annual shareholder meeting held on May 1, 2026. Shareholders elected 11 directors to one-year terms, with each nominee receiving over 104 million votes in favor.
They also ratified Ernst & Young LLP as independent auditor for 2026 with 120,123,130 votes for, approved on a nonbinding advisory basis 2025 executive compensation with 103,158,563 votes for, and rejected a shareholder proposal requesting a report on risks of misalignment between policies and customer base.
Lee Vivian S reported acquisition or exercise transactions in this Form 4 filing.
Zions Bancorporation director Vivian S. Lee received a grant of 2,055 Deferred Comp units tied to common stock at an economic value of $63.26 per unit. These phantom stock units are settled in cash upon death or retirement, bringing Lee’s total deferred units to 29,129.717.
CRITTENDEN GARY L reported acquisition or exercise transactions in this Form 4 filing.
Zions Bancorporation director Gary L. Crittenden received a compensation award of 2,055 deferred compensation units tied to the company’s common stock. The award was valued at $63.26 per unit and increases his directly held deferred comp balance to 31,748.67 units.
Each unit is economically equivalent to one share of common stock but is a phantom stock unit settled in cash rather than stock. The units are payable in cash upon the earlier of his death or retirement, making this a non‑market, cash‑settled compensation grant rather than an open‑market share purchase.
Murphy Edward F reported acquisition or exercise transactions in this Form 4 filing.
Zions Bancorporation director Edward F. Murphy received a grant of 2,055 shares of Common Stock as compensation. The shares were awarded at a value of $63.26 per share. Following this grant, Murphy directly holds a total of 43,250.678 Zions Bancorporation shares.
Skonnard Aaron reported acquisition or exercise transactions in this Form 4 filing.
Director Aaron Skonnard received a grant of deferred compensation units linked to Zions Bancorporation common stock value. The award covers 2,055 units at a reference value of $63.26 per unit, bringing his deferred comp balance to about 39,449.911 units.
Each unit is economically equivalent to one share of common stock, but the phantom stock units are settled in cash rather than actual shares. Payment occurs upon the earlier of death or retirement, making this a routine, long-term compensation grant rather than an open-market stock purchase or sale.
Gupta Suren reported acquisition or exercise transactions in this Form 4 filing.
Zions Bancorporation director Suren Gupta received a routine deferred compensation award linked to the company’s stock. On the transaction date, he was granted 2,055 deferred compensation units tied to Zions common stock at a reference price of $63.26 per unit, increasing his deferred balance to 36,411.72 units. Each unit is economically equivalent to one share of common stock but is settled in cash upon retirement or death, rather than delivering actual shares, so this filing reflects compensation accrual rather than an open-market stock purchase or sale.
Yastine Barbara A. reported acquisition or exercise transactions in this Form 4 filing.
Zions Bancorporation director Barbara A. Yastine received a grant of 2,055 shares of Common Stock on May 1, 2026, valued at $63.26 per share. This was reported as a grant or award rather than an open-market purchase. Following this award, she directly holds 25,061 shares of Zions Bancorporation Common Stock.
QUINN STEPHEN D reported acquisition or exercise transactions in this Form 4 filing.
Zions Bancorporation director Stephen D. Quinn received a compensation grant of deferred stock units tied to the company’s common stock. On the reported date, he was awarded 2,055 deferred compensation units, each economically equivalent to one share of common stock at a reference value of $63.26 per unit.
The phantom stock units will be settled in cash rather than stock, upon the earlier of his death or retirement. Following this award, Quinn’s directly held deferred compensation balance increased to 128,228.795 units. This is a routine, non‑market grant, not an open‑market stock purchase or sale.
Huang Claire A reported acquisition or exercise transactions in this Form 4 filing.
Zions Bancorporation director Claire A. Huang received a grant of 2,055 deferred compensation units on May 1, 2026. Each unit is the economic equivalent of one share of common stock and will be settled in cash upon the earlier of death or retirement.
Following this award, Huang holds a total of 34,702.427 deferred compensation units directly. This filing reflects a compensation-related grant rather than an open-market stock purchase or sale.